glp 1 wearing off Replying to @DaleXTermination🇨🇦 am I against GLP1 medications? No. I... | what is What happens when you stop
Description
In a phase 2 dose-finding trial in adults with obesity or overweight, survodutide produced dose-dependent reductions in body weight and was described as a glucagon receptorGLP-1 receptor dual agonist
Whether absolute kg or relative ratio is the right outcome depends entirely on the patient
For now, lets stick to the ones approved by the FDA and on the market
Two independent papers reported for the first time the use of GLP1R/GCGR dual agonists as being of enhanced efficacy relative to pure GLP1R agonists in the treatment of rodent obesity, with simultaneous improvement in glycemic control (44, 45)
The dispensing pharmacy and formulation details may vary based on your state, prescriber direction, and availability
The delivery system to reach millions of patients already exists
